CSK and neuroblastoma: In this study, we investigated the therapeutic potential of a c-Src tyrosine kinase inhibitor, the pyrazolo [3,4-d]pyrimidine derivative Si306, encapsulated in liposomal formulations specifically developed to recognize and kill neuroblastoma (NB) cells.